Elite Pharmaceuticals (ELTP) Amortization of Deferred Charges (2019 - 2026)
Elite Pharmaceuticals (ELTP) recorded Amortization of Deferred Charges of $110,349 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 7.6% from $119,473 a year earlier and down 3.9% from the prior quarter.
Elite Pharmaceuticals (ELTP) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends
On a TTM basis, Elite Pharmaceuticals' Amortization of Deferred Charges came in at $462,520 as of Sep 30, 2026, down 3.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $476,331, up 3.1% from FY2025.
- Across earlier fiscal years, Amortization of Deferred Charges came in at $462,030 in FY2025 (+894.8%) and $46,443 in FY2024.
- The fiscal Q2 2027 figure is the lowest quarterly Amortization of Deferred Charges since fiscal Q1 2025.
- On a year-over-year basis, Amortization of Deferred Charges has declined for three consecutive quarters, with growth averaging 29.3% over the last seven quarters.
- Per Business Quant, the preceding three fiscal quarters came in at $114,786 (Q1 2027), $117,912 (Q4 2026) and $119,473 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Elite Pharmaceuticals | 401.23 Mn | 274.64 Mn | 15.99 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 110,349.00 |
| Jun 30, 2026 | 114,786.00 |
| Mar 31, 2026 | 117,912.00 |
| Dec 31, 2025 | 119,473.00 |
| Sep 30, 2025 | 119,473.00 |
| Jun 30, 2025 | 119,473.00 |
| Mar 31, 2025 | 119,473.00 |
| Dec 31, 2024 | 119,469.00 |
| Sep 30, 2024 | 119,479.00 |
| Jun 30, 2024 | 103,609.00 |
| Mar 31, 2024 | 39,520.00 |
| Dec 31, 2019 | -48,051.00 |
| Sep 30, 2019 | -47,339.00 |
| Jun 30, 2019 | -46,635.00 |
Elite Pharmaceuticals Amortization of Deferred Charges API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortization-of-deferred-charges", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();